Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesMRIBrain MRI helps predict outcomes in cardiac arrest survivorsQuantitative brain MRI data appear to help clinicians forecast the effects of out-of-hospital cardiac arrest among those who survive it.Womens ImagingCould radiation therapy for breast cancer lower Alzheimer's risk?BreastRemoving patient fees for DBT improves utilization, but inequity remainsMolecular ImagingPET/CT metric improves staging of patients with lung cancerSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
